<?xml version="1.0" encoding="UTF-8"?>
<p>In this direction, limiting heterogeneous bioprobe presentation onto analytical surfaces is crucial to guarantee consistent device performances and reliable diagnostic outcomes (
 <xref ref-type="fig" rid="antibodies-08-00023-f002">Figure 2</xref>B).
</p>
